Thinking of joining a study?

Register your interest

NCT05549349 | Not yet recruiting | Acute Biliary Pancreatitis


ANGH Prospective Cohort of Mild and Severe Acute Biliary Pancreatitis
Sponsor:

Poissy-Saint Germain Hospital

Information provided by (Responsible Party):

Julia WORKS

Brief Summary:

The main objective of this work is to evaluate the recurrence of biliary episodes before cholecystectomy (hepatic colic, lithiasic migration, cholangitis, cholecystitis, pancreatitis, necrosis infections) in patients with acute biliary pancreatitis of any severity depending on the type of nutrition (oral, enteral or parenteral).

Condition or disease

Acute Biliary Pancreatitis

Intervention/treatment

Cholecystectomy

Detailed Description:

Acute pancreatitis (AP) is one of the frequent causes of hospitalization in gastroenterology with an annual incidence of 13-45 cases per 100,000 patients. If we refer to the data in the white paper, hospitalizations for abdominal emergencies, such as PA, take place in at least 60% of cases in General Hospital Centers (CHG). Among these AP, approximately 40% of AP are secondary to a biliary lithiasis pathology. The main modalities of the initial management of AP have been the subject of several national and international recommendations and consensuses. Although it is well accepted that early refeeding during the first 48 hours reduces the appearance of a systemic inflammatory response syndrome (SIRS) or a collection infection, the feeding methods in the event of pancreatitis Acute biliary (ABP) during the acute phase using the oral route if it is tolerated or the enteral route by nasogastric tube before cholecystectomy remains debated. Thus, in case of delayed cholecystectomy after AP, there is no consensus on the feeding methods after the acute phase (oral or enteral) until cholecystectomy nor on the benefit of a prophylactic endoscopic sphincterotomy in the absence of cholangitis.}}

Study Type : Observational
Estimated Enrollment : 2000 participants
Official Title : ANGH Prospective Cohort of Mild and Severe Acute Biliary Pancreatitis
Actual Study Start Date : October 10, 2022
Estimated Primary Completion Date : March 10, 2023
Estimated Study Completion Date : March 10, 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Adult over 18 years old
  • Affiliated to a social security scheme.
  • Patients with acute biliary pancreatitis
Exclusion Criteria
  • Patients with chronic pancreatitis
  • Patients with a previous cholecystectomy
  • Patients under guardianship, curatorship or legal protection

ANGH Prospective Cohort of Mild and Severe Acute Biliary Pancreatitis

Location Details


Please Choose a site



ANGH Prospective Cohort of Mild and Severe Acute Biliary Pancreatitis

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Loading...